Carl Zeiss Meditec AG (BIT:1AFX)

Market Cap	5.26B
Revenue (ttm)	2.08B
Net Income (ttm)	157.03M
Shares Out	n/a
EPS (ttm)	1.78
PE Ratio	33.50
Forward PE	n/a
Dividend	0.60 (1.02%)
Ex-Dividend Date	Mar 27, 2025

Volume	200
Average Volume	173
Open	59.90
Previous Close	59.30
Day's Range	59.90 - 59.90
52-Week Range	44.36 - 97.25
Beta	n/a
RSI	56.70
Earnings Date	May 14, 2025

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1846
• Employees: 5,730
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1AFX

Financial Performance

In 2024, Carl Zeiss Meditec AG's revenue was 2.07 billion, a decrease of -1.11% compared to the previous year's 2.09 billion. Earnings were 178.73 million, a decrease of -38.45%.